Abstract Background: Despite the well-documented decline in the use of metal-on-metal (MoM) implants over the last decade, there are still controversies regarding whether all MoM implants are created equally. Complications such as elevated serum metal ion levels, aseptic lymphocyte-dominated vasculitis-associated lesion (ALVAL) and pseudotumours have all been well documented, but recent studies suggest increased risk of infection with MoM bearing surfaces. Most of these studies however have small patient numbers.
Introduction
Use of metal-on-metal (MoM) implants has dramatically declined in recent years due to the complications and failures that are well documented in the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) [9] . At the start of the 21st century, MoM bearing surfaces were widely used due to expectations of lower bearing surface wear with predictions of lower need for revision, especially for young active patients [10] . However, issues relating to elevated serum metal ion levels, aseptic lymphocyte-dominated vasculitis-associated lesion (ALVAL), and pseudotumour formation have essentially reduced the use of MoM bearing surfaces in Australia from over 3000 annually at its peak to around 50 in the last few years [9] . Much of this failure was attributed to the articular surface replacement [7] (ASR; DePuy, Warsaw, IN, USA), a prosthesis now withdrawn from the market. Advocates who still use MoM argue that metallurgy, design, alignment, and fixation methods were the reasons why the ASR failed and that the MoM bearing surface still plays an important role in primary hip arthroplasty [8] .
Recent research has suggested that all MoM bearing surfaces have a higher risk of developing infection compared to other bearing surfaces [5, 6, 11, 12] , but the number of patients in these studies are small. A study performed by Bozic and his colleagues had adequate power, but the findings were limited by the use of an administrative database where modifier codes for bearing surface and other data were optional [2] . It has been postulated that the combination of metal debris, ALVAL, pseudotumour formation, and necrotic tissue provides a unique environment for bacterial proliferation in MoM implants [5] .
The aim of this study was to use the resources of the AOANJRR to examine the incidence of revision for infection in MoM bearing surfaces with comparison to all other bearing surfaces following primary hip arthroplasty performed between 2000 and 2014 for the entire nation as well as in the experience of an individual surgeon.
Patients and Methods
Data was obtained from the AOANJRR for the period 2000-2014 that included the nationally collected data as well as the The italicised section relates to infection rates on our registry for all metal on metal replacements.
specific data for the senior author's practice (MO). Inclusion criteria were primary total hip arthroplasty between 2000 and 2014. Resurfacing procedures were not included. Data obtained included the total number of cases performed, subsequent revisions, reasons for revision, and bearing surface material. Data that are collected on the AOANJRR are validated through a sequential multi-level matching process against health department record data [1] and successfully tracks over 98% of all joint replacements performed in Australia [1] . Outcomes are based on time to first revision using the Kaplan-Meier survivorship function at that time multiplied by 100. Hazard ratios (HR) from Cox proportional hazard models, adjusting for age and gender, were used to compare the rate of revision between groups. All tests are two tailed at the 5% level of significance. The AOANJRR data identifies revision for infection through a standardized form that is completed at the time of the revision. The reason for revision is entered by the surgeon, but clinical correlation with cultures or haematological markers is not required.
For the patients of the senior author, all surgeries were undertaken at the Mater Hospital, Sydney, Australia, with a posterior approach using a standardized peri-operative protocol involving 4 doses of prophylactic IV cefazolin 1 g starting at the time of induction of anaesthesia. Conditions such as space suits and laminar flow were used in every case. The MoM implant used during this period was ASR/Corail (DePuy, Warsaw, IN, USA). The Pinnacle/Corail (DePuy, Warsaw, IN, USA) with a ceramic-on-ceramic articulation was used for the remaining cases. In the single surgeon data series, subjects who underwent revision for infection after MoM procedure were cross referenced with medical records to confirm the diagnosis.
Results
As of 31st of December 2015, the number of primary total hip replacements performed since 1999 was 363,561 in Australia [1] . Included in the current analysis on a national level were (Fig. 1) . The cumulative percent revision of these implants is still rising but at a significantly slower rate [9] . At 14 years, the cumulative percent revision for all MoM implants is 19.8% [5] . Nationally, a total of 3115 revisions were performed on MoM bearing surfaces. Of these, the top 3 reasons for revision were metal-related pathology (41.2%), loosening/lysis (27.3%), and infection (10.9%) ( Table 2 ). National data documents that 341 MoM implants were revised due to infection and 266 of these were large-head MoM (76%). Revision hip replacement for infection at our single hospital made up 5.9% of all revisions performed and equated to a revision for infection rate of 0.3%, compared to a national average of 0.68%. The senior author has performed 1755 primary hip replacements over the same period of 14 years. Out of this group 91 were large-head MoM. Thirty-three or 15.2% of these patients required revision of which 5 had confirmed infection and organism. This equated to an infection rate of 5.5%. When we review the other bearing surfaces, only 20 or 1.5% of total hip replacement (THR) required revision of which 3 (0.18%) were confirmed infections (Table 3) .
For national data as a whole, the 10-year cumulative percent revision for infection of MoM bearing surfaces in primary THR was 2.5% compared to 0.8% for other bearing surfaces (hazard ratio 4.5, 95% CI 3.8-5.3, p = < 0.001) (Fig. 2) . The data regarding the senior author's experience documents that the 7-year cumulative percent revision for MoM bearing surfaces in primary THR was 36.9%, compared to 2.0% for other bearing surfaces (hazard ratio 17.08, 95% CI 8.5-34.5, p = < 0.001) (Fig.  3) . At the national level, the cumulative percent revision is significantly higher in MoM bearing surfaces compared to that in other bearings for revisions in general (Fig. 4a) and revisions specifically for infection (Fig. 4b) . In Fig. 4b , it can be seen that there is a significant divergence of the curve for MoM bearing surfaces after 3 to 4 years. The findings were similar to the senior surgeon's dataset (Fig. 5) .
Discussion
The purpose of this study was to examine the rate of revision of MoM THRs in comparison to all other bearing surfaces with particular interest in the rate of revision for infection. The cumulative percentage of revision for infection in MoM bearing surfaces in hip arthroplasty was significantly higher than that in other bearing surfaces at both the national and single-surgeon level. At the national level, revision for infection was increased by a factor of 4.5 times compared to other bearing surface. This was even more pronounced in the single-surgeon series where that hazard of revision for infection was increased by a factor of 17 times, compared to other bearing surfaces.
Interpretation of the results is difficult on a national level as there are so many different variables to consider which are not recorded. By analyzing the data at an individual level, we can control constants such as technique, approach, implant choice and post-operative care as well as confirming the organisms responsible for infection.
The AOANJRR published a supplementary report in 2015 examining the reason for the higher incidence of infection in MoM bearings [9] . It highlighted a key problem with the registry in identifying infections. They concluded that a majority of forms completed in theatres had no confirmed organism and often, the diagnosis criteria for infection was not documented [9] .
Infections in arthroplasty which present late typically result from haematogenous spread. Therefore, specific implants or bearing surfaces that increase the risk of infection are far more difficult to detect in the national registry compared to an Boutlier^implant which has an early failure rate [4] . By using the individual surgeon series, we can confirm with confidence the diagnosis of infection by isolating an organism. Unfortunately, the same level of confidence cannot be applied to the national data.
There are still important variables outstanding when it comes to patient demographics in the registry. Medications, alcohol use, diabetes, peripheral vascular disease, body mass index, and nutrition are just some of the important variables which have been implicated in increasing the infection rate of all arthroplasty surgery [3] . Therefore, the data that is presented here should be treated with caution with the focus on trends rather than absolute figures. Despite this, there is still a clear trend that large-head MoM bearing surfaces have a higher rate of infection particularly in the first 2 years after surgery. This correlates closely with the data collected from the senior surgeon where the average time to presentation for infection was 13.4 months. In addition, one of the major limitations of interpreting the single-surgeon data is the relatively small number of subjects who received a MoM bearing prosthesis (n = 91). Despite this, there is clear evidence of the increased rate of infection with the MoM prosthesis.
Metal-on-metal articulations appear to have a greater rate of revision for infection which is evident in the AOANJRR, as well as a large single-surgeon case series. The reasons for this trend have yet to be determined. 
